ORTHOCLONE OKT3 is an IgG2a murine monoclonal antibody obtained by the hybridoma technique, which is directed against a 20-kD (kilodalton) glycoprotein on the membrane of mature T cells. This glycoprotein is an integral component of the antigen-recognition structure of the T cell. The interaction of ORTHOCLONE OKT3 causes a rapid and complete removal of the glycoprotein from the T-cell surface. Our exerience with ORTHOCLONE OKT3 for the reversal of acute renal rejection has included patients who were experiencing first rejection episodes as well as patients with severe rejection who were unresponsive to previously administered antirejection therapy.
|Number of pages||7|
|Publication status||Published - 1986|
ASJC Scopus subject areas